Stockreport

Why Catalyst Pharmaceuticals (CPRX) Is Up 5.4% After Raising 2026 Revenue Guidance And Highlighting Rare Disease Portfolio [Yahoo! Finance]

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com
PDF Catalyst Pharmaceuticals recently reported past fourth-quarter 2025 revenue of US$152.61 million and full-year 2025 revenue of US$588.99 million, alongside net income o [Read more]